KL and cancer: Altogether, this strategy can serve not only to maintain and improve the quality of life in the elderly, but also to decrease the economic cost overruns to health care systems derived from pathologies that imply low levels of S-Klotho (e.g., neurological disorders, CKD, and cancer) [38,39].